Xu D - Search Results

1

Identification of a CEACAM5 targeted nanobody for positron emission tomography imaging and near-infrared fluorescence imaging of colorectal cancer.

Xiao Y, Mei C, Xu D, Yang F, Yang M, Bi L, Mao J, Pang P, Li D. Xiao Y, et al. Among authors: xu d. Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2305-2318. doi: 10.1007/s00259-023-06183-7. Epub 2023 Mar 14. Eur J Nucl Med Mol Imaging. 2023. PMID: 36914753

2

Early Diagnosis of Murine Sepsis-Associated Encephalopathy Using Dynamic PET/CT Imaging and Multiparametric MRI.

Zhu T, Jiang J, Xiao Y, Xu D, Liang Z, Bi L, Yang M, Liang M, Li D, Lin Y. Zhu T, et al. Among authors: xu d. Mol Imaging Biol. 2022 Dec;24(6):928-939. doi: 10.1007/s11307-022-01743-z. Epub 2022 May 25. Mol Imaging Biol. 2022. PMID: 35612771

3

Lu³⁺-based nanoprobe for virtual non-contrast CT imaging of hepatocellular carcinoma.

Chen J, Liu J, Xu D, Liu J, Chen X, Yang S, Yin P, Jiang Z, Mei C, Zhang X, Wang L, Zhang K, Zhou B, Shan H, Li D, Pang P. Chen J, et al. Among authors: xu d. J Control Release. 2022 Sep;349:327-337. doi: 10.1016/j.jconrel.2022.06.055. Epub 2022 Jul 12. J Control Release. 2022. PMID: 35787917

4

Inhibition of JNK/c-Jun-ATF2 Overcomes Cisplatin Resistance in Liver Cancer through down-Regulating Galectin-1.

Yang F, Li M, Xu D, Jiang Z, Jiang H, Xiao Y, Mei C, Yang M, Chen C, Zhou B, He B, Shan H, Pang P, Li D. Yang F, et al. Among authors: xu d. Int J Biol Sci. 2023 Apr 25;19(8):2366-2381. doi: 10.7150/ijbs.79163. eCollection 2023. Int J Biol Sci. 2023. PMID: 37215991 Free PMC article.

5

Novel STING-targeted PET radiotracer for alert and therapeutic evaluation of acute lung injury.

Xu D, Yang F, Chen J, Zhu T, Wang F, Xiao Y, Liang Z, Bi L, Huang G, Jiang Z, Shan H, Li D. Xu D, et al. Acta Pharm Sin B. 2023 May;13(5):2124-2137. doi: 10.1016/j.apsb.2022.12.017. Epub 2022 Dec 28. Acta Pharm Sin B. 2023. PMID: 37250155 Free PMC article.

6

STING-targeted PET tracer for early assessment of tumor immunogenicity in colorectal cancer after chemotherapy.

Xu D, Lu X, Yang F, Jiang Z, Yang S, Bi L, Liu J, Shan H, Li D. Xu D, et al. Eur J Nucl Med Mol Imaging. 2024 Feb;51(3):641-655. doi: 10.1007/s00259-023-06485-w. Epub 2023 Nov 4. Eur J Nucl Med Mol Imaging. 2024. PMID: 37924341

7

¹⁸F-labeled ethisterone derivative for progesterone receptor targeted PET imaging of breast cancer.

Gao F, Peng C, Zhuang R, Guo Z, Liu H, Huang L, Li H, Xu D, Wen X, Fang J, Zhang X. Gao F, et al. Among authors: xu d. Nucl Med Biol. 2019 May-Jun;72-73:62-69. doi: 10.1016/j.nucmedbio.2019.07.001. Epub 2019 Jul 12. Nucl Med Biol. 2019. PMID: 31330414

8

¹⁸F-labeled estradiol derivative for targeting estrogen receptor-expressing breast cancer.

Xu D, Zhuang R, You L, Guo Z, Wang X, Peng C, Zhang D, Zhang P, Wu H, Pan W, Zhang X. Xu D, et al. Nucl Med Biol. 2018 Apr;59:48-55. doi: 10.1016/j.nucmedbio.2018.01.003. Epub 2018 Feb 2. Nucl Med Biol. 2018. PMID: 29466767

9

Radioiodinated Small-Molecule Tyrosine Kinase Inhibitor for HER2-Selective SPECT Imaging.

Tang L, Peng C, Tang B, Li Z, Wang X, Li J, Gao F, Huang L, Xu D, Zhang P, Zhuang R, Su X, Chen X, Zhang X. Tang L, et al. Among authors: xu d. J Nucl Med. 2018 Sep;59(9):1386-1391. doi: 10.2967/jnumed.117.205088. Epub 2018 Apr 13. J Nucl Med. 2018. PMID: 29653973 Free PMC article.

10

Radioiodinated Portable Albumin Binder as a Versatile Agent for in Vivo Imaging with Single-Photon Emission Computed Tomography.

Wen X, Shi C, Xu D, Zhang P, Li Z, Li J, Su X, Zhuang R, Liu T, Guo Z, Zhang X. Wen X, et al. Among authors: xu d. Mol Pharm. 2019 Feb 4;16(2):816-824. doi: 10.1021/acs.molpharmaceut.8b01116. Epub 2019 Jan 15. Mol Pharm. 2019. PMID: 30604976

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,886 results

Search Page

Filters